Previous study have showed that PSMD2 regulated the cell proliferation and the cell cycle progression in breast cancer via modulation of p21 and p27 proteasomal degradation, which suggest that this protein might be a potential therapeutic target [30]. This evidence concerns the gene PSMD2 and breast carcinoma.